Tenderwize
Zurück zur Suche

Lotto 1

InnovaPuglia S.p.A.·Valenzano, Italy·EUR 5500M·Deadline Jun 18, 2029 · 1027 days left·Restricted·Supplies·DPS
Registrieren zum SpeichernOpen documents
High valueStructured notice only
Originaltitel der Bekanntmachung

Italy – Pharmaceutical products – Bando SDA FARMACI 2025 - Prodotti Farmaceutici

70/100

Opportunity Score

PromisingMedium complexity
SuppliesDPSOpen
Warum diese Bewertung?

Chance

70 / 100

Komplexität

55 / 100

Risikofaktoren

Only one selection criterion is provided (trade register registration). Other eligibility criteria (e.g., financial, te...

The estimated value is extremely high, but it may be a ceiling for the DPS; actual awarded contracts could be lower.

Restricted procedure — pre-qualification required

Tiefe Portfolioanalyse

Tiefe Analyse der Unternehmenspassung

Verwendet:

  • Description
  • Industries & Services
  • Capabilities
  • Market & Experience
  • Certifications

Überblick

Strong opportunity

Wichtige Fakten

  • EUR 5500M estimated value
  • Dynamic Purchasing System (DPS)
  • Supplies contract
  • 1 lot
  • Duration 1461 DAY
  • Supply of pharmaceutical products (CPV 33600000) to healthcare companies in the Puglia region, Italy.
  • The DPS is open for submission of indicative tenders until 18 June 2029.
Vollständige Zusammenfassung anzeigen

This notice establishes a Dynamic Purchasing System (DPS) for the supply of pharmaceutical products to healthcare companies in the Puglia region of Italy. The DPS is valued at €5.5 billion and will run for approximately 4 years (until June 2029). It is a restricted procedure with electronic submission required in Italian. Only one lot is defined. The award is based on the most economically advantageous tender (quality criteria). Selection requires registration in the trade register.

Risiken

Only one selection criterion is provided (trade register registration). Other eligibility criteria (e.g., financial, te...

The estimated value is extremely high, but it may be a ceiling for the DPS; actual awarded contracts could be lower.

Restricted procedure — pre-qualification required

Analyse kann unvollständig sein

Nur ein Teil der Vergabeunterlagen wurde analysiert. Weitere Anforderungen, Zertifikate oder Einreichungsdokumente können in den übrigen Unterlagen enthalten sein.

Wichtige Anforderungen

Technical

  • Registration in the trade register (required for participation).

Administrative

  • Electronic submission via the e-procurement platform (eproc.empulia.it).
  • All communications and documents must be in Italian.

Anforderungen können unvollständig sein.

Zuschlagskriterien

Lot 1

Offerta economicamente più vantaggiosa

Auftraggeber

Ort

Valenzano, ITA

Auftraggeberprofil

Profil öffnen

Kennung

06837080727

Tätigkeit

General public services

Lose (1)

LOT-0001

Lotto 1

Supply of pharmaceutical products to healthcare companies in Puglia (NUTS: ITF47). The lot is part of a DPS; no specific individual tender deadline is provided. Estimated value: €5,500,000,000.

SuppliesDPSEU fundedElectronic submission

EUR 5.5B

Geschätzter Wert

Ort

ITF47, Italy

Dauer

1461 DAY

Kategorie

Pharmaceutical products

Zuschlagskriterien

Offerta economicamente più vantaggiosa

Frist

Deadline Jun 18, 2029

Vergabedetails

Veröffentlichungsdatum
19 Jun 2025
Sprachen
Italian

Referenzmetadaten

Rechtsgrundlage
32014L0024

Referenz-IDs

Ausschreibungs-ID
400352-2025

Dokumente (2)

Vergabedokument 1Einreichungsportal 1

Ähnliche Ausschreibungen

Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells über Arzneimittel mit dem Handelsnamen Orylmyte(R) (ATC-Code nach WHO: V01AA03)

Aug 31

Bulgaria – Pharmaceutical products – Динамична система за покупки за доставка на лекарствени продукти за Медицински институт на МВР

Jul 9

Belgium – Pharmaceutical products – Antimycotica

Aug 27

Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells über Arzneimittel mit dem Handelsnamen Oralair(R) (ATC-Code nach WHO: V01AA02)

Aug 31

Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells zum Wirkstoff Ipratropiumbromid (ATC-Code nach WHO: R03BB01)

Sep 30

Denmark – Pharmaceutical products – Amgros 2027 1.1170.a

Sep 3